Mara Persano

irccs san raffaele scientific institute hospital

H指数:16

被引数:1,170

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From trial efficacy to real-world effectiveness: evaluating the generalizability of cisplatin–gemcitabine–durvalumab in advanced biliary tract cancers

从临床试验疗效到真实世界有效性：评估顺铂-吉西他滨-度伐利尤单抗在晚期胆道癌中的普适性

Journal of Gastroenterology

IF5.5

2026-11-040

PRE

Silvia Camera; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Federico Nichetti; Anna Saborowski; Christoph Gerdes; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Frederik Peeters; Chiara Braconi; David J. Pinato; Emiliano Tamburini; Chiara Pircher; Luisa Foltran; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Angela Lamarca; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell’Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Changhoon Yoo; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Su Yung-Yeh; Stephen L. Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Guido Giordano; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Federico Rossari; Federica Lo Prinzi; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Lorenzo Fornaro; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Arndt Vogel; Gianluca Masi; Lorenza Rimassa; Andrea Casadei-Gardini

Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real-world study

胆道癌患者接受化疗免疫疗法后的预后分层：一项回顾性多中心真实世界研究

Cancer

IF5.1

2026-09-160

PRE

Mara Persano MD; Andrea Casadei-Gardini MD; Lorenzo Fornaro MD; Tomoyuki Satake MD, PhD; Oluseyi Abidoye MD; Federica Lo Prinzi MD; Lorenzo Antonuzzo MD; Jin Won Kim MD, PhD; Francesca Bergamo MD; Melanie Bathon MD; Anna Saborowski MD; Tiziana Pressiani MD; Caterina Vivaldi MD; Ilario Giovanni Rapposelli MD; Frederik Peeters MD; Chiara Braconi MD, PhD; David J. Pinato MD, PhD; Emiliano Tamburini MD; Monica Niger MD; Stefano Tamberi MD; Florian Castet MD; Monica Verrico MD; Alessandro Parisi MD; Nuno Couto MD; Hong Jae Chon MD, PhD; Angela Lamarca MD, PhD; Guido Giordano MD; Fabian Finkelmeier MD; Ester Oneda MD; Antonio Avallone MD; Lukas Perkhofer MD; Il Hwan Kim MD, PhD; Ingrid Garajova MD; Salvatore Corallo MD; Elisabetta Fenocchio MD; Emanuela Dell’Aquila MD; Chiara Pirrone MD; Lorenzo Lucidi MD; Giulia Tesini MD; Elena Valenzi MD; Anna Diana MD; Changhoon Yoo MD, PhD; Marta Schirripa MD; Vincenzo Formica MD; Maria Grazia Rodriquenz MD; Mario Scartozzi MD; Jorge Adeva MD; Michele Ghidini MD; Gerald W. Prager MD; Giuseppe Aprile MD; Gian Paolo Spinelli MD; Su Yung-Yeh MD, PhD; Stephen L. Chan MD; Masafumi Ikeda MD; Tanios Bekaii-Saab MD; Jessica Lucchetti MD; Daniele Lavacchi MD; Minsu Kang MD; Rita Balsano MD; Francesca Salani MD; Silvia Camera MD; Gianluca Masi MD; Sara Lonardi MD; Arndt Vogel MD, PhD; Lorenza Rimassa MD; Margherita Rimini MD

Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy

胆道癌患者接受化疗免疫疗法治疗后不良事件预测作用的全球人群研究

Cancers

IF4.4

2026-09-100

Linda Bartalini; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Arndt Vogel; Angela Lamarca; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Jeroen Dekervel; Chiara Braconi; David James Pinato; Emiliano Tamburini; Chiara Carlotta Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell’Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Changhoon Yoo; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Yung-Yeh Su; Stephen L. Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Andrea Pretta; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Lorenzo Fornaro; Andrea Casadei-Gardini; Lorenza Rimassa

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab

早期肝功能失代偿与接受阿替利珠单抗联合贝伐珠单抗或度伐利尤单抗联合特瑞普利单抗治疗的HCC患者死亡率相关

Seminars in Oncology

IF2.5

2026-09-070

PRE

Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting

根据TOPAZ-1研究入组标准评估顺铂、吉西他滨和度伐利尤单抗的疗效：一项真实世界环境下的全球性大规模分析

International Journal of Cancer

IF4.7

2026-08-160

PRE

Federica Lo Prinzi; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Frederik Peeters; Chiara Braconi; David J. Pinato; Emiliano Tamburini; Chiara Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Angela Lamarca; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell'Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Yoo Changhoon; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Su Yung-Yeh; Stephen Lam Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Guido Giordano; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Arndt Vogel; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei-Gardini

Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real-World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab

探索系统性治疗后的手术治疗在局部晚期胆道癌中的作用：来自接受顺铂、吉西他滨和度伐利尤单抗治疗的大型回顾性跨国真实世界队列的结局

International Journal of Cancer

IF4.7

2026-08-150

PRE

Margherita Rimini; Angela Lamarca; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Arndt Vogel; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Frederik Peeters; Chiara Braconi; David J. Pinato; Emiliano Tamburini; Chiara Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell'Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Yoo Changhoon; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Su Yung-Yeh; Stephen L. Chan; Iakov Bolnykh; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Massimo Giuseppe Viola; Silvia Bozzarelli; Mara Persano; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Francesca Ratti; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei-Gardini

Durvalumab–Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data From the LOR-HCC (Lombardy Real-World HCC Group)

度伐鲁单抗–曲美木单抗在晚期肝细胞癌中的应用：来自LOR-HCC（伦巴第真实世界HCC研究组）的真实世界数据

Liver International

IF5.2

2026-04-160

OAAI

Andrea Casadei-Gardini; Lorenzo Canova; Federica Tosi; Silvia Camera; Elisa Bocchero; Pietro Pozzoni; Martina Torchio; Salvatore Corallo; Daniela Costantino; Annamaria Stagno; Giulia Grizzi; Rita Gengarle; Gianluca Tomasello; Nasim Ansarin; Mariangela Bruccoleri; Katia Bencardino; Mara Persano; Martina Pino; Alessia Riva; Sara Vavassori; Lorenzo Argiento; Chiara Mazzarelli; Massimo De Giorgio; Elena Rota Caremoli; Margherita Rimini; Tiziana Pressiani; Lorenza Rimassa; Massimo Iavarone

Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers

度伐利尤单抗在晚期胆道癌中的应用：来自多个国际中心大型患者队列的真实世界数据

LIVER INTERNATIONAL

IF5.2

2025-11-120

OAAI

Rimini, Margherita; Fornaro, Lorenzo; Ikeda, Masafumi; Abidoye, Oluseyi; Lucchetti, Jessica; Antonuzzo, Lorenzo; Kim, Jin Won; Nichetti, Federico; Saborowski, Anna; Pressiani, Tiziana; Vivaldi, Caterina; Rapposelli, Ilario Giovanni; Peeters, Frederik; Braconi, Chiara; Pinato, David J.; Tamburini, Emiliano; Pircher, Chiara; Tamberi, Stefano; Castet, Florian; Verrico, Monica; Parisi, Alessandro; Couto, Nuno; Chon, Hong Jae; Martirena, Andrea; Lamarca, Angela; Landriscina, Matteo; Fimkelmeier, Fabian; Oneda, Ester; Avallone, Antonio; Dell'Aquila, Emanuela; Perkhofer, Lukas; Kim, Il Hwan; Pinto, Cidalia Maria de Sousa; Garajova, Ingrid; Kang, Beodeul; Corallo, Salvatore; Fenocchio, Elisabetta; Farinea, Giovanni; Pastorino, Alessandro; Diana, Anna; Changhoon, Yoo; Schirripa, Marta; Rodriquenz, Maria Grazia; Scartozzi, Mario; Zumstein, Lucrezia; Ghidini, Michele; Prager, Gerald W.; Aprile, Giuseppe; Spinelli, Gian Paolo; Yung-Yeh, Su; Chan, Stephen; Warmington, Emily; Lancianese, Alessia; Bekaii-saab, Tanios; Lavacchi, Daniele; Kang, Minsu; Lonardi, Sara; Vogel, Arndt; Prete, Alessandra Anna; Bozzarelli, Silvia; Salani, Francesca; Persano, Mara; Masi, Gianluca; Balsano, Rita; Niger, Monica; Camera, Silvia; Passeri, Laura; Ferrara, Michele; Satake, Tomoyuki; Rimassa, Lorenza; Casadei-Gardini, Andrea

Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study

仑伐替尼与索拉非尼在肝移植后复发性HCC中的疗效与安全性比较：一项多中心真实世界研究

HEPATOLOGY RESEARCH

IF3.4

2025-11-010

PRE

Lo Prinzi, Federica; Rossari, Federico; De Rosa, Antonio; Vivaldi, Caterina; Kudo, Masatoshi; Shimose, Shigeo; Suda, Goki; Camera, Silvia; Foti, Silvia; Rizzato, Mario Domenico; Salani, Francesca; Nishida, Naoshi; Shirono, Tomotake; Sakamoto, Naoya; Passeri, Laura; Ferrara, Michele; Solda, Caterina; Cesario, Silvia; Ueshima, Kazuomi; Niizeki, Takashi; Sho, Takuya; Persano, Mara; Vitiello, Francesco; Invernizzi, Federica; Lonardi, Sara; Masi, Gianluca; Rimini, Margherita; Gardini, Andrea Casadei

Genomic Pathway Alterations and Their Prognostic Impact in Biliary Tract Cancer: Insights from a Multinational Cohort Treated with Cisplatin, Gemcitabine, and Durvalumab

基因组通路改变及其在胆道癌中的预后影响：来自接受顺铂、吉西他滨和度伐利尤单抗治疗的跨国队列的见解

European Journal of Cancer

IF7.1

2025-10-030

PRE

Chiara Pirrone; Umberto Malapelle; Francesco Pepe; Federica Lo Prinzi; Federico Nichetti; Anna Saborowski; Lorenzo Antonuzzo; Silvia Camera; Tomoyuki Satake; Frederik Peeters; Caterina Vivaldi; Tiziana Pressiani; Jessica Lucchetti; Jin Won Kim; Oluseyi Abidoye; Ilario Giovanni Rapposelli; Stefano Tamberi; Fabian Finkelmeier; Guido Giordano; Chiara Pircher; Hong Jae Chon; Chiara Braconi; Aitzaz Qaisar; Alessandro Pastorino; Florian Castet; Emiliano Tamburini; Changhoon Yoo; Alessandro Parisi; Anna Diana; Mario Scartozzi; Gerald W. Prager; Antonio Avallone; Salvatore Corallo; Marta Schirripa; Il Hwan Kim; Lukas Perkhofer; Ester Oneda; Monica Verrico; Jorge Adeva; Stephen L. Chan; Gian Paolo Spinelli; Nicola Personeni; Ingrid Garajova; Maria Grazia Rodriquenz; Silvana Leo; Cecilia Melo Alvim; Ricardo Roque; Giovanni Farinea; Francesca Salani; Caterina De Grandis; Daniele Lavacchi; Mara Persano; Masafumi Ikeda; Jeroen Dekervel; Monica Niger; Rita Balsano; Giuseppe Tonini; Minsu Kang; Tanios Bekaii-Saab; Luca Esposito; Alessandra Boccaccino; Vera Himmelsbach; Matteo Landriscina; Francesco De Cobelli; Francesca Ratti; Francesca Daniel; Giulia Tesini; Gianluca Masi; Arndt Vogel; Sara Lonardi; Margherita Rimini; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei-Gardini

Letter Re: Reflections on the MAGIC-D Prognostic Model in Advanced Biliary Tract Cancer

信函事由：关于MAGIC-D预后模型在晚期胆道癌中的反思

Liver International

IF5.2

2025-09-060

PRE

Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study

伊沃西登ib治疗IDH1突变型肝内胆管癌：一项多中心真实世界研究的见解

Liver International

IF5.2

2025-08-260

OAAI

Monica Niger; Margherita Rimini; Florian Castet; Anna Melzer; Mario Domenico Rizzato; Tiziana Pressiani; Daniele Lavacchi; Giuseppe Aprile; Torsello Angela; Tiziana Saladino; Noventa Silvia; Pasqua Cito; Alessandro Pastorino; Eduardo Terán-Brage; Carolina Sciortino; Silvia Camera; Chiara Pircher; Mara Persano; Vincenzo Mazzaferro; Silvia Foti; Kreina Sharela Vega; Thomas J. Ettrich; Lorenzo Antonuzzo; Lorenza Rimassa; Sara Lonardi; Lukas Perkhofer; Teresa Macarulla; Filippo Pietrantonio; Andrea Casadei-Gardini

Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting

Atezolizumab联合Bevacizumab与Tremelimumab联合Durvalumab在真实世界环境中肝细胞癌（HCC）患者中的比较疗效

Targeted Oncology

IF4

2025-06-230

PRE

Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population

阿特珠单抗联合贝伐珠单抗与仑伐替尼对比用于巴塞罗那临床肝癌分期B期（BCLC-B）肝细胞癌（HCC）患者：一项真实世界人群研究

Seminars in Oncology

IF2.5

2025-06-090

PRE

HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions

TARGETED ONCOLOGY

IF4

2025-02-220

PRE

Lenvatinib (L) versus sorafenib (S) second-line therapy in hepatocellular carcinoma (HCC) patients (P) progressed to atezolizumab plus bevacizumab (AB)

仑伐替尼（L）与索拉非尼（S）在进展至阿替利珠单抗联合贝伐珠单抗（AB）方案后的肝细胞癌（HCC）患者（P）中的二线治疗

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab

SCIENTIFIC REPORTS

IF3.9

2024-08-301

OAAI

Rimini, Margherita; Montes, Margarida; Amadeo, Elisabeth; Vitiello, Francesco; Kudo, Masatoshi; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Lonardi, Sara; Finkelmeier, Fabian; Salani, Francesca; Antonuzzo, Lorenzo; Marra, Fabio; Iavarone, Massimo; Cabibbo, Giuseppe; Foschi, Francesco Giuseppe; Silletta, Marianna; Sacco, Rodolfo; Rapposelli, Ilario Giovanni; Scartozzi, Mario; Nicoletta, Pella; Aldrighetti, Luca; Persano, Mara; Camera, Silvia; Rossari, Federico; Foti, Silvia; Kumada, Takashi; Hiraoka, Atsushi; Iwamoto, Hideki; Rizzato, Mario Domenico; Himmelsbach, Vera; Masi, Gianluca; Corradi, Mattia; Celsa, Ciro; Fabio, Conti; Frassineti, Giovanni Luca; Cascinu, Stefano; Casadei-Gardini, Andrea; Presa, Jose

Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents

EXPERT OPINION ON INVESTIGATIONAL DRUGS

IF4.1

2024-07-220

PRE

Treatment options for advanced hepatocellular carcinoma: the potential of biologics

晚期肝细胞癌的治疗选择: 生物制剂的潜力

EXPERT OPINION ON BIOLOGICAL THERAPY

IF4

2024-06-243

PRE

A real-world, multicenter study of atezolizumab plus bevacizumab in viral and non-viral advanced hepatocellular carcinoma patients from Asia and Europe